Scandinavian life science sector attracts investors

A new report from Stockholm-based venture capital investor Industrifonden shows a great interest for life science companies in Scandinavia, with a total investment of $2.4bn from 2014 to the third quarter of 2016. One of several trends is that venture capital funds this year have increased focus on IPO’s, and this trend looks set to continue.These figures and trends are reported in Scandinavian Life Science Funding Report, 2014-2016, commissioned by Industrifonden, which has 15 life science companies in its portfolio. The report is a thorough analysis of the investment landscape and